Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7739162 | 1.00 | CYP2D6 (0.32) | CYP2D6ALDH1A1TRIM24TRIM33 | |
| SCHEMBL7739574 | 1.00 | CYP2D6 (0.32) | CYP2D6ALDH1A1TRIM24TRIM33 | |
| SCHEMBL258235 | 1.00 | CYP2D6 (0.32) | CYP2D6ALDH1A1TRIM24TRIM33 | |
| SCHEMBL258288 | 1.00 | — | — | |
| SCHEMBL258147 | 0.96 | — | — | |
| SCHEMBL170393 | 0.81 | — | — | |
| SCHEMBL493847 | 0.76 | — | — | |
| SCHEMBL6688188 | 0.73 | — | — | |
| SCHEMBL3800069 | 0.73 | — | — | |
| SCHEMBL23012685 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109942549-A | A kind of low alkalinity polymerized hindered amine light stabilizer and preparation method thereof | 北京天罡助剂有限责任公司 | 2019-06-28 | — | — | CN | claimed |
| CN-109265995-A | A kind of polymerized hindered amine light stabilizer and its application | 北京天罡助剂有限责任公司 | 2019-01-25 | — | — | CN | claimed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| CN-115210219-A | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| EP-3044208-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-12-22 | — | — | EP | disclosed |
| CN-113316744-A | Oxime ester photoinitiators with specific aroyl chromophores | 巴斯夫欧洲公司 | 2021-08-27 | — | — | CN | disclosed |
| CN-108440370-B | Inhibitors of viral replication | 鲁汶天主教大学 | 2021-07-30 | — | — | CN | disclosed |
| CN-105283451-B | Novel inhibitors of viral replication | 鲁汶天主教大学 | 2021-01-26 | — | — | CN | disclosed |
| US-10793555-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2020-10-06 | — | — | US | disclosed |
| CN-109942549-A | A kind of low alkalinity polymerized hindered amine light stabilizer and preparation method thereof | 北京天罡助剂有限责任公司 | 2019-06-28 | — | — | CN | disclosed |
| US-20040157814-A1 | 6, 7-Oxygenated steroids and uses related thereto | INFLAZYME PHARMACEUTICALS LTD. (CA) | 2004-08-12 | — | — | US | disclosed |
| US-6706701-B1 | SAFE AND EFFECTIVE RELIEF OF ASTHMA AND ALLERGY SYMPTOMS | INFLAZYME PHARMACEUTICALS LTD. (CA) | 2004-03-16 | — | — | US | disclosed |
| EP-1304333-A2 | 6,7-Oxygenated steroids and uses related thereto | Inflazyme Pharmaceuticals, Ltd. (CA) | 2003-04-23 | — | — | EP | disclosed |
| EP-0917534-B1 | 6,7-OXYGENATED STEROIDS AND USES RELATED THERETO | INFLAZYME PHARM LTD (CA) | 2002-12-04 | — | — | EP | disclosed |
| US-6410748-B1 | Alicycli c group-containing monomer | KABUSHIKI KAISHA TOSHIBA (JP) | 2002-06-25 | — | — | US | disclosed |
| US-6291129-B1 | LIGHT SENSITIVE ELEMENT WITH UNSATURATED POLYMERS | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-09-18 | — | — | US | disclosed |
| US-6046185-A | 6,7-oxygenated steroids and uses related thereto | INFLAZYME PHARMACEUTICALS LTD. (CA) | 2000-04-04 | — | — | US | disclosed |
| EP-0917534-A2 | 6,7-OXYGENATED STEROIDS AND USES RELATED THERETO | Inflazyme Pharmaceuticals, Ltd. (CA) | 1999-05-26 | — | — | EP | disclosed |
| WO-1998002450-A2 | 6,7-OXYGENATED STEROIDS AND USES RELATED THERETO | INFLAZYME PHARMACEUTICALS LTD. (CA) | 1998-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793555-B2 | Oxime ester photoinitiators | NR2E3, OXER1, CBR3 | CYP2D6 214/4885ALDH1A1 929/4885TRIM24 3077/4885 |
| US-20040157814-A1 | 6, 7-Oxygenated steroids and uses related thereto | CYP11B1, CYP11B2, CYP21A2 | CYP2D6 75/4885ALDH1A1 1065/4885TRIM24 4497/4885 |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | CYP2D6 350/4885ALDH1A1 964/4885TRIM24 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.